Implementation of dapagliflozin as adjunctive therapy in type 1 diabetes: A single centre real-world experience.

Show simple item record

dc.contributor.authorRaj, Arjun
dc.contributor.authorBansiya, Vishakha
dc.contributor.authorEvans, Mark L
dc.contributor.authorBoughton, Charlotte K
dc.date.accessioned2022-01-05T10:49:56Z
dc.date.available2022-01-05T10:49:56Z
dc.date.issued2022-06
dc.date.submitted2021-10-17
dc.identifier.issn0742-3071
dc.identifier.otherdme14764
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/332013
dc.languageen
dc.publisherWiley
dc.subjectLETTER
dc.subjectLETTERS
dc.titleImplementation of dapagliflozin as adjunctive therapy in type 1 diabetes: A single centre real-world experience.
dc.typeOther
dc.date.updated2022-01-05T10:49:56Z
prism.publicationNameDiabet Med
dc.identifier.doi10.17863/CAM.79461
dcterms.dateAccepted2021-12-08
rioxxterms.versionofrecord10.1111/dme.14764
rioxxterms.versionAO
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.contributor.orcidBoughton, Charlotte K [0000-0003-3272-9544]
dc.identifier.eissn1464-5491
cam.issuedOnline2021-12-16


Files in this item

Thumbnail
Name:
dme.14764.xml
Size:
5Kb
Format:
XML
Description:
Bibliographic metadata
View / Open Files
Thumbnail
Name:
dme.14764.pdf
Size:
126Kb
Format:
PDF
Description:
Published version
View / Open Files

This item appears in the following Collection(s)

Show simple item record